Quarterly Research Grant for Parkinson’s Disease

The Quarterly Research Grant Funding Programme by Cure Parkinson’s supports preclinical and clinical research projects aimed at modifying Parkinson’s disease. This open funding opportunity is available internationally, with a focus on projects that can potentially translate into clinical testing within five years. The next application deadline is 18 January 2027. The programme focuses on funding research that aims to slow, stop, or reverse Parkinson’s disease. Cure Parkinson’s prioritizes projects with a clear path to clinical testing within five years, excluding studies aimed solely at symptomatic relief. Clinical projects must involve individuals with Parkinson’s, rather than healthy volunteers. This funding programme is crucial for advancing research that seeks to modify Parkinson’s disease, potentially leading to significant breakthroughs in treatment approaches. By fostering projects with real-world clinical applications, Cure Parkinson’s supports efforts to find a cure. What types of projects are funded? Projects that aim to slow, stop, or reverse Parkinson’s disease, excluding those focused on symptomatic relief. What is the maximum funding amount for preclinical projects? Up to £300,000 for projects lasting up to 36 months. Who can apply for the grant? International academic institutions and commercial entities. What is the application deadline for 2026? The application deadline is 18 January 2027, 23:59 BST. How is the application process structured?

A two-stage process: initial application (Stage 1) and, if successful, a full application (Stage 2) followed by peer review.

Eligible researchers and organizations should review the official Cure Parkinson’s Application Guidelines thoroughly and ensure compliance with all requirements before submission.